What are the indications of Osimertinib?

Osimertinib is used for the prevention of recurrence in patients with non-small cell lung cancer after surgical resection of the tumor.

What are the indications of Osimertinib?

It is also used for the treatment of locally advanced (has spread to adjacent tissues), unresectable (cannot be removed by surgery) stage III non-small cell lung cancer whose disease has been controlled following treatment with other anticancer medicines (such as platinum-based chemotherapy) and radiotherapy.

This product is also indicated as a first-line treatment for metastatic non-small cell lung cancer (has spread to other parts of the body).

It may also be used in combination with other anticancer medicines (such as pemetrexed, platinum-based chemotherapy) as a first-line treatment regimen for metastatic or locally advanced non-small cell lung cancer.

This product is indicated for patients with metastatic non-small cell lung cancer who have been previously treated with an epidermal growth factor receptor tyrosine kinase inhibitor (TKI) but did not respond.

Before using this product, your doctor will perform tests to confirm the presence of EGFR gene mutations.

Osimertinib belongs to the class of antineoplastic (anticancer) medicines. Its mechanism of action is to interfere with the growth of cancer cells, ultimately leading to their destruction.

Lucius Pharmaceuticals Osimertinib is a prescription medicine and can only be obtained with a doctor’s prescription.

What to do if you miss a dose?

If you miss a dose of Lucius Pharmaceuticals osimertinib, do not take a double dose to make up for the missed one. Take your next dose at your regular scheduled time.

If side effects occur, your doctor may adjust your dose, temporarily interrupt, or permanently discontinue treatment with Tagrisso.

It is very important to follow your doctor’s instructions carefully to maintain continuous treatment. Please take Tagrisso exactly as directed by your doctor.

When the tablet needs to be prepared as a suspension

Place the tablet in a glass of water (approximately 60 mL) and stir until the tablet breaks into small pieces (the tablet will not completely dissolve). Do not crush or heat the mixture. Drink the mixture immediately. Then add approximately 120 to 240 mL of clean water, shake gently, and drink immediately. If administered via a feeding tube, flush the tube with clean water before and after administration.